ストックスクリーナーアプリを入手
61.97
1.37%
0.84
アフターアワーズ：
61.97
前日終値:
$61.13
開ける：
$61.13
24時間の取引高:
471.19K
Relative Volume:
1.13
時価総額：
$1.92B
収益：
$1.29B
当期純損益:
$131.74M
株価収益率:
14.72
EPS:
4.21
ネットキャッシュフロー:
$166.13M
1週間 パフォーマンス:
-1.87%
1か月 パフォーマンス:
-9.89%
6か月 パフォーマンス:
-13.87%
1年 パフォーマンス:
-23.30%
1日の値動き範囲:
$61.13
$63.04
1週間の範囲:
$59.50
$63.88
52週間の値動き範囲:
$59.50
$86.96
Conmed Corp Stock (CNMD) Company Profile
CNMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
61.97 | 1.92B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-01 | 繰り返されました | Needham | Buy |
| 2023-05-22 | 開始されました | CL King | Buy |
| 2023-03-27 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-10-06 | アップグレード | Needham | Hold → Buy |
| 2021-07-15 | 開始されました | UBS | Buy |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2019-11-26 | ダウングレード | Needham | Buy → Hold |
| 2019-11-12 | 開始されました | JP Morgan | Overweight |
| 2019-10-31 | 繰り返されました | Needham | Buy |
| 2019-10-04 | 繰り返されました | Needham | Buy |
| 2019-08-22 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | 開始されました | Stifel | Buy |
| 2019-04-16 | 繰り返されました | Needham | Buy |
| 2019-01-23 | 繰り返されました | Needham | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-08-07 | 繰り返されました | Needham | Buy |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-04-26 | 繰り返されました | Needham | Buy |
| 2018-02-01 | 繰り返されました | Needham | Buy |
| 2017-07-27 | 繰り返されました | Needham | Buy |
| 2017-04-27 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | 繰り返されました | Needham | Buy |
| 2016-11-18 | 繰り返されました | Needham | Buy |
| 2016-07-28 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | 繰り返されました | Needham | Buy |
| 2015-10-22 | 繰り返されました | Northland Capital | Market Perform |
すべてを表示
Conmed Corp (CNMD) 最新ニュース
CONMED (NYSE:CNMD) Sets New 52-Week LowWhat's Next? - MarketBeat
Olympiad Research LP Makes New $340,000 Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Purchased by Principal Financial Group Inc. - MarketBeat
Allspring Global Investments Holdings LLC Grows Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corporation Faces Rising Business Risks Amid Global Supply Chain Challenges - TipRanks
CONMED Corp SEC 10-K Report - TradingView
CONMED Co. (NYSE:CNMD) Short Interest Update - MarketBeat
Conmed's chief information officer sells $16,796 in common stock - MSN
Yousif Capital Management LLC Sells 285 Shares of CONMED Co. (NYSE:CNMD) - Defense World
CONMED Co. (NYSE:CNMD) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Conmed's chief information officer sells $16,796 in common stock By Investing.com - Investing.com Australia
CONMED Co. (NYSE:CNMD) Shares Sold by Choreo LLC - Defense World
abrdn plc Has $9.40 Million Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Prepare Yourself for Liftoff: Conmed Corp (CNMD) - SETE News
CONMED (NYSE:CNMD) Given New $91.00 Price Target at Needham & Company LLC - MarketBeat
CONMED (NYSE:CNMD) Price Target Lowered to $70.00 at Wells Fargo & Company - MarketBeat
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
CONMED (NYSE:CNMD) Downgraded to "Neutral" Rating by JPMorgan Chase & Co. - MarketBeat
CONMED (NYSE:CNMD) Given New $75.00 Price Target at Stifel Nicolaus - MarketBeat
CONMED (NYSE:CNMD) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
CONMED (NYSE:CNMD) Updates FY 2025 Earnings Guidance - MarketBeat
CONMED Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Wells Fargo & Company Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Stifel Nicolaus Forecasts Strong Price Appreciation for CONMED (NYSE:CNMD) Stock - Defense World
Market Resilience: Conmed Corp (CNMD) Finishes Weak at 67.36, Down -8.97 - The Dwinnex
CONMED (NYSE:CNMD) Shares Gap Down After Analyst Downgrade - MarketBeat
Taking a look at what insiders are doing to gauge the Conmed Corp (CNMD)’s direction - Knox Daily
Behind Conmed Corp’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Needham & Company LLC Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Armenian Reporter
Breaking Down Conmed: 4 Analysts Share Their Views - Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Needham cuts CONMED stock target to $91, maintains Buy rating - Investing.com
CONMED Corporation (NYSE:CNMD) Q4 2024 Earnings Call Transcript - Insider Monkey
CONMED Beats Analysts' Q4 Expectations Despite Full-Year Forecast ShortfallNews and Statistics - IndexBox, Inc.
These Analysts Slash Their Forecasts On Conmed After Q4 Results - Benzinga
JPMorgan cuts CONMED stock rating, lowers price target to $70 - Investing.com
Conmed: Q4 Earnings Snapshot - The Advocate
Conmed Corp (CNMD) Q4 2024 Earnings Call Highlights: Strong Growth in General Surgery and ... - Yahoo Finance
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings - MSN
CONMED earnings beat by $0.13, revenue topped estimates - Investing.com
Conmed Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops By Stock Story - Investing.com Canada
Conmed Q4 Earnings Assessment - Benzinga
Conmed Q4 Earnings Summary & Key Takeaways - Benzinga
Insights into Conmed Q4 Earnings - Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops - Yahoo Finance
Conmed Corp (CNMD) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
0.57%
大文字化:
|
ボリューム (24 時間):